[go: up one dir, main page]

DK1032407T3 - Use of putamen ovi - Google Patents

Use of putamen ovi

Info

Publication number
DK1032407T3
DK1032407T3 DK98962374T DK98962374T DK1032407T3 DK 1032407 T3 DK1032407 T3 DK 1032407T3 DK 98962374 T DK98962374 T DK 98962374T DK 98962374 T DK98962374 T DK 98962374T DK 1032407 T3 DK1032407 T3 DK 1032407T3
Authority
DK
Denmark
Prior art keywords
putamen ovi
ovi
putamen
medicaments
locally
Prior art date
Application number
DK98962374T
Other languages
Danish (da)
Inventor
Michel O Ruepp
Original Assignee
Aar Pharma Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aar Pharma Gmbh & Co Kg filed Critical Aar Pharma Gmbh & Co Kg
Application granted granted Critical
Publication of DK1032407T3 publication Critical patent/DK1032407T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Paper (AREA)

Abstract

The invention relates to the use of treated putamen ovi in the production of medicaments which can be administered orally or locally for treatment and prevention.
DK98962374T 1997-11-21 1998-11-20 Use of putamen ovi DK1032407T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19751681A DE19751681A1 (en) 1997-11-21 1997-11-21 Use of Putamen ovi
PCT/EP1998/007477 WO1999026641A1 (en) 1997-11-21 1998-11-20 Use of putamen ovi

Publications (1)

Publication Number Publication Date
DK1032407T3 true DK1032407T3 (en) 2004-01-12

Family

ID=7849459

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98962374T DK1032407T3 (en) 1997-11-21 1998-11-20 Use of putamen ovi

Country Status (9)

Country Link
EP (1) EP1032407B1 (en)
AT (1) ATE249229T1 (en)
AU (1) AU1756299A (en)
CA (1) CA2311546A1 (en)
DE (2) DE19751681A1 (en)
DK (1) DK1032407T3 (en)
ES (1) ES2207020T3 (en)
WO (1) WO1999026641A1 (en)
ZA (1) ZA9810603B (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558771A (en) * 1968-02-12 1971-01-26 Leslie L Balassa Process for using eggshell compositions for promoting wound healing
GB2218906A (en) * 1988-05-27 1989-11-29 Anne Mcmanus Medicament for treatment of skin disorders
CS445488A1 (en) * 1988-06-24 1991-01-15 Karol Mvdr Michalek Biological preparation for osteo- and chondropathies,physiopathological disorders and diseases arisen on base of mineral deficiency in human organism treatment
CN1079149A (en) * 1993-04-09 1993-12-08 李洪洋 A kind of biological calcium element and preparation method thereof
DE4422613A1 (en) * 1994-06-28 1996-01-04 Aar Pharma Adler Apotheke Putamen ovi
NL1002400C2 (en) * 1996-02-20 1997-08-21 Friesland Brands Bv Oral calcitonin preparation and method of recovering calcitonin.
DE19627376A1 (en) * 1996-07-06 1998-01-08 Aar Pharma Adler Apotheke Use of Artichoke (Cynara) extracts
DE19639375A1 (en) * 1996-09-25 1998-04-02 Aar Pharma Mistletoe dry extracts
DE19700788A1 (en) * 1997-01-11 1998-07-16 Michael O Ruepp Use of a dry extract of St. John's wort

Also Published As

Publication number Publication date
EP1032407B1 (en) 2003-09-10
ATE249229T1 (en) 2003-09-15
ZA9810603B (en) 1999-08-02
ES2207020T3 (en) 2004-05-16
CA2311546A1 (en) 1999-06-03
WO1999026641A1 (en) 1999-06-03
AU1756299A (en) 1999-06-15
DE19751681A1 (en) 1999-07-29
EP1032407A1 (en) 2000-09-06
DE59809592D1 (en) 2003-10-16

Similar Documents

Publication Publication Date Title
IS4972A (en) Use of the chelating agent clioquinol in the manufacture of a pharmaceutical composition for the treatment of Alzheimer's disease
GB9807639D0 (en) Anti-inflammatory agents
DK0880350T3 (en) Treatment of disseminated sclerosis
ATE399553T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DEXTROMETHORPHAN AND QUINIDENE FOR THE TREATMENT OF NEUROLOGICAL DISEASES
DE69510940D1 (en) PYRAZOLO AND PYRROLOPYRIDINE
DK0713701T3 (en) 2-Bromelatonin for the treatment of sleep disorders
NO954996L (en) Use of nona and decapeptides for the manufacture of a medicament for the treatment of AIDS
BR9807523A (en) Quinoxalins in triple combination with protease inhibitors and reverse transcriptase inhibitors as drugs for the treatment of AIDS.
EE9900118A (en) Use of H +, K + -ATPase Inhibitors in the Treatment of Nasal Polyps
DK0946157T3 (en) Topical use of kappa-opioid agonists for the treatment of eye pain
FI960850A0 (en) Use of quinoxalins in combination with protease inhibitors as drugs in the treatment of AIDS and / or HIV infections
PT1007040E (en) UTILIZATION OF FANKINONE IN THE TREATMENT OF ALZHEIMER'S DISEASE
NO990450L (en) Treatment of mental disorders
HUP0100611A2 (en) Triazine compounds for treatment of cns disorders
NO20032597L (en) Use of SARP-1 for the treatment and / or prevention of scleroderma
DK1032407T3 (en) Use of putamen ovi
ATE262362T1 (en) USE OF CYAMEMAZINE TO TREAT WITHDRAWING SYMPTOMS OF BENZODIAZEPINE TREATMENT
ATE236633T1 (en) TOPICAL USE OF LOPERAMIDE TO TREAT MICROBIAL INFECTIONS
ATE361757T1 (en) STABLE FUMAGILLIN FORMULATION
DE60017136D1 (en) TREATMENT OF ANGIOGENESIS-DEPENDENT DISEASES WITH DEXTRINSULPHATE
DK1212072T3 (en) Pharmaceutical composition comprising eucalyptus and orange oil
BR9801839A (en) Analgesic medication and application of (+) -0-demethyltramadol.
FI972637A0 (en) Use of vitamin K in the treatment of hyperthyroidism
EP1143981A4 (en) Treatment and prevention of hiv and other viral infections
DK1007047T3 (en) Use of mizolastine in the manufacture of a medicament intended for the treatment of inflammation